Dr. Ainsley MacLean is President of Ainsley Health, a Harvard-trained neuroradiologist, and one of the foremost clinical AI leaders in the United States. She served as Chief AI Officer and Chief Medical Information Officer for Kaiser Permanente's Washington, D.C. region, where she led the deployment of artificial intelligence across a patient population of 12 million people, work spanning use case selection, vendor evaluation, clinical validation, and the change management that determines whether clinicians actually adopt a tool.

She founded the Permanente AI Center of Excellence, advised on Kaiser Permanente's first national AI strategy, and served as a member of Kaiser Permanente Ventures. She serves as senior medical advisor to clinical AI companies, is an Entrepreneur in Residence at Yale University, and remains in clinical practice.

She has been recognized by 100 Women in AI, named to the HITLAB Breakthrough Alliance Board, and featured in The New York Times on the responsible use of AI in medical decision-making.

Rebecca Geist is Chief Executive Officer of Ainsley Health, where she helps health plans, provider organizations, and healthcare innovators win and grow in Medicaid and Medicare. Clients bring her in when the stakes are high: a major state procurement, a new market entry, a value-based strategy that has to hold up financially, or a solution that needs the right partners behind it.

She has led billion-dollar RFP pursuits for the largest national payers, owning strategy end to end: bid architecture, competitive positioning, solution design, and the solution partners a winning response depends on. At Kaiser Permanente she served as National Director of Government Programs Business Development Strategy, overseeing Medicaid and Medicare business development, producing the organization’s highest-scoring Medicaid applications, managing the partner solutions ecosystem for government programs, and partnering with Kaiser Permanente Ventures on investment strategy. She previously led value-based care and provider payment innovation for UnitedHealthcare’s West Region and Medicaid proposal development at Optum.

For Ainsley Health clients, that means working with someone who has sat on the payer side of the table. Rebecca knows how states evaluate bids, how health plans choose partners, and how networks and payment models have to be built to perform, and she brings that insight to every engagement.

Dr. Nadia Smati is an internal medicine physician and clinical faculty member at Houston Methodist and a clinical informatics fellow at Baylor College of Medicine. She earned her undergraduate degree from Stanford University and her medical degree from Imperial College London. Her clinical training in NHS England and at Kaiser Permanente informs her approach to technology integration across diverse care delivery models and frontline clinical workflows. Dr. Smati leads clinical AI education for physicians, focusing on safety, equity, and bias mitigation in clinical practice. She is a frequent speaker on clinical innovation and digital transformation, and her work in AI-enabled patient–physician communication and health literacy has received national recognition from the American College of Physicians. She also serves as a partner at Ainsley Health, a healthcare strategy firm, where she advises health systems and health technology companies on enterprise AI governance and implementation strategy.

Dr. Adam Eltorai is a physician-scientist and board-certified practicing radiologist with expertise in clinical AI implementation, clinical evidence strategy, and translational research, spanning medicine, biomedical engineering, and biotechnology. He has published numerous peer-reviewed articles and books, including multiple works on AI in healthcare.

Dr. Amit Mehta is a physician entrepreneur and health-IT investor who leads a venture capital firm's health-IT practice, guiding founders from seed through Series B. He founded and served as Chief Medical Officer of Intrinsic Imaging, which ran clinical trials in 64 countries and was acquired by WCG Clinical in 2021, and his expertise spans clinical trials, medical imaging, device development, and AI.

Research Associate. Supports the team across market and policy research, client deliverables, and outcomes documentation.

Dr. Griffin L. Davis is a board-certified emergency medicine physician and healthcare executive who served as Chief Clinical Officer for Holy Cross Health, with executive responsibility for clinical operations across two acute care hospitals generating $750 million in annual revenue. He is Adjunct Professor of Emergency Medicine at The George Washington University School of Medicine and Health Sciences, and his work spans service line redesign, throughput and capacity, provider productivity, and data analytics.

Professor Hatim Abdulhussein is the Chief Executive Officer for Health Innovation Kent Surrey Sussex, one of England’s Fifteen Regional Health Innovation Clusters commissioned by the government and the National Health Service, and is a practising GP in North West London. Academically, he is a Professor of Innovation and AI in the School of Medicine at the University of Surrey, a Senior Clinical Lecturer in General Practice in the School of Medicine at Keele University and Faculty of the Institute for Healthcare Improvement. As an international speaker, he has contributed to the publication of academic papers and white papers spanning workforce, education reform, innovation, primary care, digital health, and AI. Professor Abdulhussein is an advocate for safe, ethical, and responsible digital and AI transformation and ensuring workforce preparedness for innovations and technologies in health and care.

James helps organizations turn emerging technology into practical business systems. His work spans AI agents, workflow automation, internal tools, customer engagement platforms, and growth infrastructure designed to improve operations and service delivery.

With experience building technology across healthcare and small-business environments, he combines product thinking, technical implementation, and market strategy to help organizations move from ideas to working systems.

Technology Strategy. Founder and CEO of a healthcare technology company building agentic AI for revenue cycle management.

Jim Hickman is a nationally recognized leader in healthcare policy, innovation, and system transformation. For more than three decades, he has helped organizations translate complex policy into scalable models that improve access, equity, and outcomes.

He serves healthcare organizations and entrepreneurs, advising on policy strategy, market alignment, innovation, and scaling in Medicaid and public-sector markets. He also advises Health Inno New Mexico on pathways for adopting new care models.

Jim is a senior advisor to the Camden Coalition’s National Center for Complex Health and Social Needs and supports CalAIM implementation across California. His work aligns policy, financing, technology, and delivery systems, grounded in the belief that technology enables, but relationships transform.

Dr. Joanna MacLean is a Harvard-trained psychiatrist specializing in women's behavioral medicine and reproductive mental health, serving as Director of Women's Behavioral Medicine at Brown University Health and Associate Professor at the Warren Alpert Medical School. She designs care pathways, screening protocols, and referral structures for integrated behavioral and physical health.

Karen Smith Thiel leverages decades of federal and state health care policy expertise to help Ainsley Health clients navigate complex regulatory environments, shape policy outcomes, and advance strategic business objectives. She advises clients on strategic planning, legislative and regulatory engagement, and advocacy initiatives, helping organizations anticipate change, identify opportunities, and respond effectively to evolving health care policies.

Drawing on senior-level experience with the U.S. Department of Health and Human Services and its agencies and a major health plan, Karen guides clients in developing and executing strategies that align with federal and state priorities. She helps organizations position themselves to engage proactively with federal agencies, including the Centers for Medicare and Medicaid Services, the National Institutes of Health, and the Centers for Disease Control and Prevention, enabling them to address emerging regulatory challenges and capitalize on policy developments.

Karen has extensive experience representing clients before Congressional committees and staff and brings a deep understanding of the regulatory process—from policy development through implementation. She works closely with clients to influence policy discussions, navigate regulatory pathways, and achieve meaningful outcomes.

Her expertise spans innovative pharmaceuticals, medical devices, screening and prevention services, and health information technologies, allowing her to support both emerging companies and established corporations as they bring new products to market and expand their reach. Karen also provides strategic guidance on the intersection of federal regulatory agencies, state Medicaid programs, health plans, hospitals, provider systems, and advocacy organizations.

Mohammad Malik is a senior healthcare executive with over two decades in healthcare operations, AI deployment, medical imaging, and enterprise strategy, and previously led technology deployment and infrastructure development at Kaiser Permanente. His work spans stack assessment, structured vendor evaluation, contract terms tied to delivered performance, and portfolio management.

Dr. Oghuz Anwar is a practicing hospitalist specializing in internal medicine and comprehensive inpatient care, with residency training completed within Kaiser Permanente. His active inpatient practice grounds the firm's operations work in throughput, discharge planning, and the multi-condition patients who drive length of stay and readmission risk.

Sarah Powell is a Board Certified Behavior Analyst, bringing more than 11 years of experience in the ABA field and over a decade as a BCBA. Her career has spanned direct clinical care, multi-site clinical leadership, quality assurance, organizational growth, and executive-level consulting, giving her a unique understanding of both the clinical and operational components required to build and sustain high-quality ABA organizations.

Sarah partners with ABA organizations nationwide on clinical and operational consulting, compliance and quality assurance, documentation audits, startup and expansion support, accreditation readiness, policy and procedure development, EMR implementation, staff training, recruiting, and fractional clinical leadership. Whether helping a new organization build its foundation or supporting an established provider through growth and quality improvement, Sarah is known for identifying gaps and developing practical, sustainable solutions that teams can actually implement.

Sarah believes strong operations should support, not compete with, clinical quality. Her collaborative, solutions-focused approach combines clinical expertise, operational insight, and real-world leadership experience to help ABA organizations strengthen their systems, support their teams, remain audit-ready, and grow without compromising the quality of care they provide.

Dr. Tyler Berzin is Associate Professor of Medicine at Harvard Medical School and Director of the Advanced Endoscopy Fellowship at Beth Israel Deaconess Medical Center. With over 200 peer-reviewed publications, his work in AI-assisted endoscopy has contributed directly to FDA approvals for AI diagnostic tools used in clinical practice.